Trexquant Investment’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.42M Buy
199,242
+45,679
+30% +$1.01M 0.05% 572
2025
Q1
$2.85M Buy
153,563
+92,843
+153% +$1.73M 0.03% 736
2024
Q4
$804K Sell
60,720
-37,152
-38% -$492K 0.01% 1162
2024
Q3
$3.28M Buy
97,872
+71,158
+266% +$2.38M 0.04% 637
2024
Q2
$669K Sell
26,714
-5,803
-18% -$145K 0.01% 1145
2024
Q1
$732K Buy
32,517
+10,685
+49% +$241K 0.01% 1031
2023
Q4
$468K Buy
21,832
+11,318
+108% +$242K 0.01% 1104
2023
Q3
$189K Buy
+10,514
New +$189K ﹤0.01% 1350
2023
Q2
Sell
-23,603
Closed -$514K 1406
2023
Q1
$514K Buy
+23,603
New +$514K 0.01% 986
2020
Q1
Sell
-20,153
Closed -$327K 1075
2019
Q4
$327K Buy
20,153
+11,385
+130% +$185K 0.02% 708
2019
Q3
$307K Buy
+8,768
New +$307K 0.03% 610
2019
Q2
Sell
-6,774
Closed -$495K 782
2019
Q1
$495K Buy
6,774
+3,293
+95% +$241K 0.04% 588
2018
Q4
$222K Buy
+3,481
New +$222K 0.01% 878
2018
Q2
Sell
-4,760
Closed -$495K 878
2018
Q1
$495K Buy
+4,760
New +$495K 0.03% 637